- Home
- GDTC vs HUIZ Comparison
GDTC vs HUIZ Comparison
Compare GDTC & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- HUIZ
- Stock Information
- Founded
- GDTC 2018
- HUIZ 2006
- Country
- GDTC Singapore
- HUIZ China
- Employees
- GDTC N/A
- HUIZ N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- GDTC Health Care
- HUIZ Finance
- Exchange
- GDTC Nasdaq
- HUIZ Nasdaq
- Market Cap
- GDTC 29.4M
- HUIZ 33.3M
- IPO Year
- GDTC 2023
- HUIZ 2020
- Fundamental
- Price
- GDTC $2.23
- HUIZ $2.57
- Analyst Decision
- GDTC Buy
- HUIZ
- Analyst Count
- GDTC 1
- HUIZ 0
- Target Price
- GDTC $5.00
- HUIZ N/A
- AVG Volume (30 Days)
- GDTC 15.9K
- HUIZ 18.7K
- Earning Date
- GDTC 01-01-0001
- HUIZ 03-24-2025
- Dividend Yield
- GDTC N/A
- HUIZ N/A
- EPS Growth
- GDTC N/A
- HUIZ N/A
- EPS
- GDTC N/A
- HUIZ N/A
- Revenue
- GDTC $330,254.00
- HUIZ $171,105,205.00
- Revenue This Year
- GDTC $14.71
- HUIZ N/A
- Revenue Next Year
- GDTC N/A
- HUIZ $16.92
- P/E Ratio
- GDTC N/A
- HUIZ N/A
- Revenue Growth
- GDTC N/A
- HUIZ 4.46
- 52 Week Low
- GDTC $1.20
- HUIZ $2.15
- 52 Week High
- GDTC $4.05
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- GDTC 34.89
- HUIZ 30.27
- Support Level
- GDTC $1.98
- HUIZ $2.61
- Resistance Level
- GDTC $2.56
- HUIZ $2.68
- Average True Range (ATR)
- GDTC 0.18
- HUIZ 0.17
- MACD
- GDTC -0.04
- HUIZ -0.06
- Stochastic Oscillator
- GDTC 31.25
- HUIZ 6.06
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.